1. Home /
  2. Natural Gas

Natural Gas

Midday Update: Stocks Mixed as Healthcare Struggles, Tech Continues Gains

Stocks were mixed at midday Monday as Merck weighed on the Dow and tech strength boosted the Nasdaq.

Watch: Jim Cramer Thinks Regulators Would Approve a CVS-Aetna Deal

Amid reports that CVS Health is in discussions to purchase health insurance giant Aetna for $66 billion, TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer thinks regulators would approve such a deal.

Video: Jim Cramer: I Don't Want to Panic and Sell Celgene

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer doesn't advise panicking over Celgene.

5 Products You Didn't Know Were Made By Pfizer

Pfizer is reportedly planning to sell its consumer healthcare business in an auction next month

Eli Lilly Had a Good Quarter but Investors Don't Want Health Stocks: Jim Cramer

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer said Eli Lilly LLY had a good quarter but the stock is getting hit by a rotation, as opposed to its specific performance.

Eli LIlly Beats, Sears Cuts Whirlpool: Tuesday's Top Stories

Top stories today: Eli Lilly is raising its projections for the entire year since its newer drugs are doing well, Sears stops selling Whirlpool appliances in their stores and President Trump meets with lawmakers to discuss tax reform.

Dr. Oz Welcomes Amazon's Desires to Enter the Pharmacy Business

Famed television host Dr. Oz supports Amazon's potential move into the pharmacy business, pointing to the company's track record of lowering prices for consumers.

Jim Cramer Reveals One Part of Schlumberger's Results That 'Freaked People Out'

Schlumberger shares are down 25% since the start of the year.

Gilead Sciences Yescarta Drug Approved By FDA

Shares of Gilead Sciences rose 2% Thursday after the FDA approved its Yescarta lymphoma cancer therapy drug.

Amazon's HQ2, Cancer Therapy Approved: Thursday's Top Stories

Today's Top Stories: Amazon's deadline to submit a proposal to build a new headquarters is today, Gilead shares are jumping as a result of the FDA's approval of a cancer treatment, today marks the 30th anniversary of Black Monday.